2016: NIH FOIA office withholds all records related to exclusive license on HER2+ breast cancer treatment technology
Other KEI comments on NIH licenses are found here: /nih-licenses
In response to a February request under the Freedom of Information Act (FOIA) for documents related to the grant of an exclusive patent license on a HER2+ breast cancer treatment technology, the National Institutes of Health (NIH) withheld in full all responsive records.